Bin Li
Impact in
- Rehabilitation top 0.5%
- Wound Healing and Treatments
- Immunology top 2%
- Psoriasis: Treatment and Pathogenesis
- Immune cells in cancer
Papers in
- Immunology 80
- Psoriasis: Treatment and Pathogenesis 67
- Immune Response and Inflammation 8
-
- Wound Healing and Treatments 27
- Co-authors
- Xin Li (67 shared papers)Le Kuai (70 shared papers)Fulun Li (19 shared papers)Ying Luo (50 shared papers)Yi Ru (50 shared papers)Hui Wang (1 shared paper)Xiaoguang Li (1 shared paper)Ruiai Chu (1 shared paper)
- Journals
- Evidence-based Complementary and Alternative Medicine (17 papers)Journal of Ethnopharmacology (17 papers)Medicine (8 papers)International Immunopharmacology (8 papers)Frontiers in Pharmacology (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Bin Li
259 papers receiving 5.4k citations
Bin Li's Hit Papers
Peers
Comparison fields: 5 of 152
- Rehabilitation 552
- Immunology 1.2k
- Complementary and alternative medicine 350
- Dermatology 211
- Nephrology 232
Countries citing papers authored by Bin Li
This map shows the geographic impact of Bin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Li more than expected).
Fields of papers citing papers by Bin Li
This network shows the impact of papers produced by Bin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Li. The network helps show where Bin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 272 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma Hit paper breakdown → | 2015 | 636 |
| 2 | Microenvironment‐Based Diabetic Foot Ulcer Nanomedicine Hit paper breakdown → | 2022 | 301 |
| 3 | 2019 | 228 | |
| 4 | 2012 | 131 | |
| 5 | 2019 | 124 | |
| 6 | 2023 | 120 | |
| 7 | 2016 | 113 | |
| 8 | 2014 | 94 | |
| 9 | 2015 | 84 | |
| 10 | 2016 | 84 | |
| 11 | 2024 | 81 | |
| 12 | 2015 | 72 | |
| 13 | 2008 | 69 | |
| 14 | 2011 | 67 | |
| 15 | 2022 | 67 | |
| 16 | 2009 | 60 | |
| 17 | 2016 | 60 | |
| 18 | 2006 | 59 | |
| 19 | 2016 | 59 | |
| 20 | 2015 | 54 |
About Bin Li
Bin Li is a scholar working on Immunology, Rehabilitation, Complementary and alternative medicine, Dermatology and Nephrology, having authored 272 papers that have together received 5.5k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (67 papers), Wound Healing and Treatments (27 papers), Dermatology and Skin Diseases (13 papers), Gout, Hyperuricemia, Uric Acid (12 papers), Traditional Chinese Medicine Studies (9 papers), Immune Response and Inflammation (8 papers), Diabetic Foot Ulcer Assessment and Management (8 papers) and Acupuncture Treatment Research Studies (8 papers). The work is most often cited by research in Rehabilitation (552 citations), Immunology (1.2k citations), Complementary and alternative medicine (350 citations), Dermatology (211 citations) and Nephrology (232 citations). Bin Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xin Li, Le Kuai, Fulun Li, Ying Luo, Yi Ru, Hui Wang, Xiaoguang Li, Ruiai Chu, Jingquan Li and Peizhan Chen. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, Journal of Ethnopharmacology, Medicine, International Immunopharmacology and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.